Lansdowne, PA, United States of America

John Michael Jushchyshyn


Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 58(Granted Patents)


Company Filing History:


Years Active: 1997-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: John Michael Jushchyshyn: Innovator in Pharmaceutical Science

Introduction

John Michael Jushchyshyn is a notable inventor based in Lansdowne, PA (US). He has made significant contributions to the field of pharmaceutical science, holding a total of 3 patents. His work focuses on innovative solutions for treating various medical conditions.

Latest Patents

One of Jushchyshyn's latest patents is related to Eprosartan arginyl charge-neutralization-complex and a process for its preparation and formulation. This invention pertains to a compound designed to block angiotensin II receptors, which is crucial for treating hypertension, congestive heart failure, and renal failure. The compound is specifically identified as (E)-&agr;-[2-n-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene-2-thiophenepropionic acid arginyl charge-neutralization-complex. The patent also includes methods for producing compositions containing this compound.

Career Highlights

Jushchyshyn has been associated with SmithKline Beecham Corporation, where he has contributed to various research and development projects. His expertise in pharmaceutical formulations has been instrumental in advancing the company's product offerings.

Collaborations

Throughout his career, Jushchyshyn has collaborated with several professionals, including Ricky Holland and Manga R Gudipati. These collaborations have fostered innovation and enhanced the development of new pharmaceutical solutions.

Conclusion

John Michael Jushchyshyn is a distinguished inventor whose work in pharmaceutical science has led to valuable patents and advancements in medical treatments. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…